Navigation Links
Optimer Pharmaceuticals Reports Second Quarter 2012 Financial Results
Date:7/31/2012

SAN DIEGO, July 31, 2012 /PRNewswire/ -- Optimer Pharmaceuticals, Inc. (NASDAQ: OPTR) today announced the Company's financial results for the quarter ended June 30, 2012.

(Logo: http://photos.prnewswire.com/prnh/20090413/LA97352LOGO)

Second Quarter 2012 Financial Highlights:

  • DIFICID® second quarter gross sales of $18.0 million and net sales of $15.2 million, represent increases of 9% and 6% over the first quarter, respectively
  • DIFICID ex-wholesaler treatments shipped in the second quarter to hospitals, retail pharmacies and long-term care facilities increased by 11%
  • Surpassed the first-year net sales goal established with Cubist, triggering a $5 million milestone payment due to Cubist
  • Total revenues were $49.8 million, including $19.9 million for partnering with Astellas in Japan and a $12.6 million milestone from Astellas Pharma Europe for the launch of DIFICLIR™ in the EU
  • Cash, cash equivalents and short-term investments at June 30 totaled $130.6 million
  • Net loss for the second quarter was $296,000, or $0.01 per share
  •  

    "July marked the one-year anniversary of the launch of DIFICID, and we are very proud of our accomplishments. We've generated $51.1 million in net sales and shipped almost 21,000 treatments of DIFICID since launch through the end of June this year," stated Pedro Lichtinger, President and Chief Executive Officer of Optimer. "Both demand for, and access to, DIFICID continue to grow, as scientific and health economic understanding is being expanded through more than 90 publications to date. We are confident in DIFICID's potential to meet our expectations in 2012 and also maintain expectations for reaching break-even within 3 years of launch."

    Financial Overview
    Total revenues for the thr
    '/>"/>

    SOURCE Optimer Pharmaceuticals, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10

    Related biology technology :

    1. MAP Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock
    2. Global Biopharmaceuticals Market 2011-2015
    3. Patient Advocate Foundation and Jazz Pharmaceuticals Announce Partnership for Narcolepsy CareLine
    4. Convergence Pharmaceuticals Announces Successful Completion of Phase I for CNV2197944 and Plans Phase II Studies in Neuropathic Pain
    5. Oramed Pharmaceuticals Granted 2nd Patent in New Zealand; 3rd Patent for Core Technology on Oral Delivery of Proteins
    6. Keryx Biopharmaceuticals to Present at The 7th Annual JMP Securities Healthcare Conference
    7. Auxilium Pharmaceuticals, Inc. to Present At The JMP Securities 2012 Healthcare Conference
    8. Access Pharmaceuticals to Report New MuGard Clinical Trial Data This Week at the MASCC/ISOO Symposium in New York City
    9. Keryx Biopharmaceuticals Announces Live Webcast of Upcoming Analyst Day
    10. Auxilium Pharmaceuticals, Inc. to Present at the Jefferies 2012 Global Healthcare Conference
    11. Questcor Pharmaceuticals to Present at Jefferies 2012 Global Healthcare Conference
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/28/2014)... According to the ... Instruments, Services), Methods (Phenotypic, Genotypic), Applications (Pharmaceutical, Diagnostic, Environmental, ... - Global Forecasts to 2019" published by ... at $896.5 Million in 2014 and is ... growing at a CAGR of 5.9% from ...
    (Date:7/28/2014)... July 28, 2014 Immunomic Therapeutics, Inc. ... to further develop potential treatments for glioblastoma multiforme (GBM), ... combination with their patented vaccine platform, LAMP-vax. , ... are based on the work of John H. Sampson, ... The Preston Robert Tisch Brain Tumor Center at Duke ...
    (Date:7/28/2014)... St Louis, MO (PRWEB) July 28, 2014 ... tools, software, and services that bring the power of ... for the inaugural Appistry Pipeline Challenge . ... Callum Bell, president of the National Center for Genome ... Children’s Mercy Hospitals and Clinics of Kansas City. Rounding ...
    (Date:7/28/2014)... (PRWEB) July 28, 2014 The global ... billion by 2020, according to a new study by ... the rising demand for effective vaccines and drugs in ... unmet medical needs is expected to drive market demand ... to enhance agricultural productivity via the use of genetically ...
    Breaking Biology Technology:Microbial Identification Market worth $1,194.1 Million by 2019 2Microbial Identification Market worth $1,194.1 Million by 2019 3String of Collaborations Launch Immunomic Therapeutics’ Brain Tumor Program Pipeline 2String of Collaborations Launch Immunomic Therapeutics’ Brain Tumor Program Pipeline 3String of Collaborations Launch Immunomic Therapeutics’ Brain Tumor Program Pipeline 4Appistry Names Industry Experts from the National Center for Genome Resources and Mercy Children's, Kansas City, to Judge Pipeline Challenge Competition 2Global Biotechnology Market Worth $604.40 Billion by 2020: Grand View Research, Inc 2Global Biotechnology Market Worth $604.40 Billion by 2020: Grand View Research, Inc 3Global Biotechnology Market Worth $604.40 Billion by 2020: Grand View Research, Inc 4
    ... 1938 to the impact of the Krakatoa eruption of 1883, ... of extreme weather. Now an international team of climatologists have ... 1871 to the present day, and from the earth,s surface ... Reanalysis Project, outlined in the Quarterly Journal of the ...
    ... done and now they,ve done it. What,s more, they did ... U.S. Department of Energy (DOE),s Lawrence Berkeley National Laboratory (Berkeley ... the first experimental demonstration of GRIN for gradient index ... a wide range of exotic optics, including superfast computers based ...
    ... Amgen (Nasdaq: AMGN ) today announced that it ... results on Monday, Jan. 24, 2011 after the close of ... conference call with the investment community at 2:00 p.m. Pacific ... Sharer, chairman and chief executive officer, and other members of ...
    Cached Biology Technology:The 20th Century Reanalysis Project: A time machine for climate scientists 2The 20th Century Reanalysis Project: A time machine for climate scientists 3GRIN plasmonics 2GRIN plasmonics 3GRIN plasmonics 4Amgen Announces Webcast of 2010 Fourth Quarter and Full Year Financial Results 2
    (Date:7/28/2014)... of people in the United States have a circulatory ... can be painful and may even require surgery in ... muscle wasting and, in turn, limb amputation. , At ... (UTHealth) Medical School, scientists tested a non-surgical preventative treatment ... was associated with increased blood circulation. Their proof-of-concept ...
    (Date:7/28/2014)... at Yale School of Medicine have pinpointed a mechanism in ... levels in the blood, linking it to both type 1 ... July 28 issue of Proceedings of the National Academies ... endopeptidase enzyme located in a part of the hypothalamus ... steps in motion that control glucose levels in the blood," ...
    (Date:7/28/2014)... Eight of the top 10 U.S. cities that have ... public inconveniences as frequent road closures, overwhelmed storm drains ... a new NOAA technical report. , This nuisance flooding, ... three U.S. coasts, between 300 and 925 percent since ... Nuisance Flood Frequency Changes around the United States, also ...
    Breaking Biology News(10 mins):Scientists discover genetic switch that can prevent peripheral vascular disease in mice 2Glucose 'control switch' in the brain key to both types of diabetes 2NOAA: 'Nuisance flooding' an increasing problem as coastal sea levels rise 2NOAA: 'Nuisance flooding' an increasing problem as coastal sea levels rise 3
    ... be tough, but scientists have found a Yellowstone National ... simple one-celled algae called Cyanidioschyzon -- thrives ... occurs naturally around hot springs, said Tim McDermott, professor ... at Montana State University. Cyanidioschyzon could ...
    ... is a commonly used indicator organism for detecting the ... of E. coli as an indicator organism has ... this important microorganism in groundwater environments. Commonly only a single ... studies, yet research has shown that a significant amount of ...
    ... March 6, 2009 -- As the first plant life ... earth, bryophytes offer a unique opportunity for researchers to ... three varieties of bryophites (liverworts, hornworts, and mosses) have ... local environments, but with the recent effects of climate ...
    Cached Biology News:Montana State team finds Yellowstone alga that detoxifies arsenic 2Montana State team finds Yellowstone alga that detoxifies arsenic 3Transport behavior of E. coli varies depending on manure source 2How increased UV exposure impacts plants 2
    ... use spatulas have been designed to save ... for those interested in eliminating the recycling ... spatula is individually packaged, RNase/DNase free, non-pyrogenic ... a new product number, created to easily ...
    ... been designed to save time and provide ... in eliminating the recycling and resterilizing necessary ... packaged, RNase/DNase free, non-pyrogenic and antistatic. Linkage: ... number, created to easily match Cornings product ...
    ... spatulas have been designed to save time ... those interested in eliminating the recycling and ... is individually packaged, RNase/DNase free, non-pyrogenic and ... new product number, created to easily match ...
    ... a base medium for preparation of minimal and ... but does not contain amino acids. Both bulk ... pouch contains reagents to prepare 500 ml of ... of 10X YNB for S. cerevisiae media. Store ...
    Biology Products: